Delivery Order 75F40120D00028-75F40121F19002
Award Date 9/30/21
Potential Completion Date 9/29/25
Potential Value $25M
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Time and Materials
Place of Performance
Hartford, CT 06156, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $2.68 million delivery order against the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ to Iqvia Government Solutions Inc. The one-year order, with a period of performance from September 2020 through September 2021, will provide products and services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS effort. Under a time...
- The Food and Drug Administration (FDA), through its Center for Biologics Evaluation and Research (CBER), awarded a $6.16 million delivery order on September 27, 2024, to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative #3, focused on Health Care Data Sources for Surveillance of Biologics. This contract, which operates on a time and materials pricing model with an ultimate completion date of October 30, 2025, will be performed in Falls Church,...
- This is a delivery order awarded to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics indefinite delivery, indefinite quantity (IDIQ) contract with the Food and Drug Administration (FDA). The $17,498,031.84 award will provide data sources to conduct surveillance of biologics, covering tens of millions of patients from insurers, payers, and providers. The BEST Initiative IDIQ is valued at $50 million and...
- The Department of Health and Human Services Food and Drug Administration awarded a $5.1 million delivery order against the BEST Initiative - Data Sources for Surveillance of Biologics master IDIQ contract. The order is for BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS, and will be performed by The Lewin Group, Inc., doing business as Lewin Group Inc., a subsidiary of UnitedHealth Group Incorporated. Work will take place in Mosby, Virginia...
- This is a $4,415,338.31 delivery order contract awarded by the Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a prominent for-profit healthcare data and analytics provider. The contract is for the CBER's Biologics Effectiveness and Safety (BEST) Initiative #3, which focuses on utilizing healthcare data sources for surveillance of biologics (BEST 3). The contract is a time and materials type with a period of...
- The U.S. Department of Health and Human Services Food and Drug Administration awarded a $14,609,200.89 delivery order contract to International Business Machines Corporation (IBM) for the "DEVELOPMENT OF NEW AND INNOVATIVE METHODS FOR AUTOMATED REPORTING FOR CBER-REGULATED BIOLOGICAL PRODUCTS". This contract is a Time and Materials type under the BEST Initiative - New and Innovative Methods for Automated Reporting master IDIQ. The contract does not have a set-aside designation. IBM, as...
- This is a delivery order awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to develop and enhance the current Center for Biologics Evaluation and Research (CBER) capabilities with respect to electronic health data sources, infrastructure, methods, and tools. The purpose is to conduct surveillance and epidemiologic studies to assure the safety and effectiveness of biologic products including...
- The Food and Drug Administration awarded a $5.45M definitive contract on September 26, 2025, to Acumen LLC (doing business as Medric) for the CBER Biologics Effectiveness and Safety (BEST) Initiative BEST1 Coordinating Center. Under the time-and-materials contract, Medric will provide data analytics, technical assistance, and program coordination services supporting FDA's Center for Biologics Evaluation and Research (CBER) in monitoring the safety and effectiveness of biologic products. The...
- This is a $8,256,834.00 Delivery Order contract awarded by the Food and Drug Administration (FDA) to The Lewin Group, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract supports the FDA's Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative #3, which focuses on health care data sources for surveillance of biologics. This is a Time and Materials contract with a performance period through September 29, 2025. The Lewin Group has...
- The Food and Drug Administration (FDA) awarded a $12,945,264.27 delivery order contract to Harvard Pilgrim Health Care Inc. (HPHC) to provide services for the Sentinel Operations Center (SOC). The contract, which runs through June 30, 2025, is a labor hours contract with no set-aside designation. HPHC, a non-profit healthcare organization, will leverage its expertise in health data analytics, epidemiology, and program management to maintain and enhance the FDA's Sentinel Initiative, a...